المؤلفون: Lin C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., DiCioccio RA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Haykal T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., McManigle WC; Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Li Z; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Anand SM; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan., Poe JC; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Bracken SJ; Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Jia W; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Alyea EP 3rd; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Cardones AR; Division of Dermatology, Department of Internal Medicine, University of Kansas Medical Center, Lawrence, Kansas., Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Lopez R; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Martin M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Minor KK; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Quinones VLP; Duke Eye Center, Durham, North Carolina., Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Rizzieri DA; Novant Health Cancer Institute, Charlotte, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: stefanie.sarantopoulos@duke.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Mar; Vol. 29 (3), pp. 179.e1-179.e10. Date of Electronic Publication: 2022 Dec 25.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Bronchiolitis Obliterans Syndrome* , Graft vs Host Disease*/prevention & control, Humans ; Animals ; Mice ; Neoplasm Recurrence, Local/complications ; Aminopyridines/therapeutic use ; Oxazines/pharmacology ; Oxazines/therapeutic use ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Steroids/therapeutic use ; Syk Kinase/therapeutic use